Revvity | PKI - 资产



金融业
股票价格
USD 156.99
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 19.46B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


资产 更改 日
Agilent USD 13.97B 902M 2026-06
Align Technology USD 6.42B 103.41M 2026-06
Bio Techne USD 2.59B 36.12M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Celltrion KRW 779.18B 10.37B 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Danaher USD 93.28B 914M 2026-09
Dentsply International USD 5.2B 25M 2026-06
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Illumina USD 6.65B 91M 2026-06
Intuitive Surgical USD 19.35B 1.53B 2026-09
IQVIA Holdings USD 29.88B 206M 2026-06
Kangmei Pharma CNY 13.07B 239.31M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Laboratory Of America USD 18.53B 554.8M 2026-06
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
OraSure Technologies USD 360.55M 18.62M 2026-06
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pacific Biosciences Of California USD 751.85M 30.51M 2026-06
Pharma Mar EUR 393.6M 8.34M 2026-06
Qiagen NV USD 5.89B 107.14M 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Quidel USD 5.72B 86.6M 2026-06
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
Tilray USD 2.1B 15.95M 2025-09
Waters USD 24.75B 220M 2026-06
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.51B 129.02M 2026-06